Results 21 to 30 of about 34,840 (229)

A Novel Human Luteinizing Hormone Receptor Gene [PDF]

open access: yesThe Journal of Clinical Endocrinology & Metabolism, 1998
A novel human luteinizing hormone receptor (LHR) gene was isolated from a human placental genomic library. This gene (Gene II) differs from that previously isolated from a lymphocyte library (Gene I) by several base changes in the 5' flanking region and the deletion of 6 nucleotides in the coding region (+55 to +60).
C H, Tsai-Morris   +3 more
openaire   +2 more sources

Receptors for luteinizing hormone-releasing hormone. [PDF]

open access: yesJournal of Histochemistry & Cytochemistry, 1978
Antisera to luteinizing hormone-releasing hormone (LH-RH) confer on Araldite sections of occasional rat pituitaries moderate immunocytochemical staining to the large secretory granules of gonadotrophs. Treatment of the sections with LH-RH before anti-LH-RH yields strong staining in all animals, irrespective of presence or absence of staining without ...
openaire   +2 more sources

Regulation of human luteinizing hormone receptor in the ovary [PDF]

open access: yesReproductive Medicine and Biology, 2008
The luteinizing hormone receptor (LHR) is essential for elevated levels of progesterone to maintain pregnancy during the first trimester; the maintenance of the expression of LHR is a key factor controlling the duration of luteal function. Therefore, as the expression of LHR is most likely to be regulated by the stability of the receptor mRNA at the ...
Takashi, Minegishi   +4 more
openaire   +2 more sources

Regulation of gene expression in ovarian cancer cells by luteinizing hormone receptor expression and activation

open access: yesBMC Cancer, 2011
Background Since a substantial percentage of ovarian cancers express gonadotropin receptors and are responsive to the relatively high concentrations of pituitary gonadotropins during the postmenopausal years, it has been suggested that receptor ...
Dam Phuongan   +6 more
doaj   +1 more source

A case of micropenis caused by compound heterozygote mutations in luteinizing hormone/choriogonadotropin receptor (LHCGR) [PDF]

open access: yesJichu yixue yu linchuang, 2022
Objective To investigate the pathogenic gene mutations and clinical characteristics in a patient with compound heterozygote gene mutations in luteinizing hormone/choriogonadotropin receptor (LHCGR) gene.
YANG Yu-fan, ZHAO Ya-ling, WANG Xi, NIE Min, WU Xue-yan, MAO Jiang-feng
doaj   +1 more source

Hinge region mediates signal transmission of luteinizing hormone and chorionic gonadotropin receptor

open access: yesComputational and Structural Biotechnology Journal, 2022
Luteinizing hormone-choriogonadotropin receptor (LHCGR), a class A G protein-coupled receptor (GPCR), plays a pivotal role in the maturation of reproductive organs and embryonic development.
Xinheng He   +7 more
doaj   +1 more source

Antisense mRNA for NPY-Y1 receptor in the medial preoptic area increases prolactin secretion

open access: yesBrazilian Journal of Medical and Biological Research, 1999
We investigated the participation of neuropeptide Y-Y1 receptors within the medial preoptic area in luteinizing hormone, follicle-stimulating hormone and prolactin release.
N.A. Silveira, C.R. Franci
doaj   +1 more source

Clinical aspect, pathogenesis and therapy options of alopecia induced by hormonal therapy for breast cancer

open access: yesExploration of Targeted Anti-tumor Therapy, 2021
Adjuvant hormonal therapy is one of the most important treatments of hormone-receptor-positive breast cancer and includes selective estrogen receptor modulators, aromatase inhibitors, and luteinizing hormone-releasing hormone analogs.
Alfredo Rossi   +4 more
doaj   +1 more source

Molecular Mechanisms of Dysregulated LH and FSH Secretion in Human Reproductive Failure

open access: yesBiomedicines
Several reproductive issues in both men and women are caused by changes in the pulsatile secretion of luteinizing hormone (LH) and follicle-stimulating hormone (FSH).
Athanasios Zikopoulos   +9 more
doaj   +1 more source

Ovarian Function Suppression With Luteinizing Hormone-Releasing Hormone Agonists for the Treatment of Hormone Receptor-Positive Early Breast Cancer in Premenopausal Women

open access: yesFrontiers in Oncology, 2021
Chemotherapy and endocrine therapies are mainstays of treatment for early and advanced hormone receptor-positive (HR+) breast cancer. In premenopausal women with HR+ tumors, the benefits of adding ovarian function suppression (OFS) to endocrine therapy ...
Yen-Shen Lu, Andrea Wong, Hee-Jeong Kim
doaj   +1 more source

Home - About - Disclaimer - Privacy